Accendra Health Inc
ACCH- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- SEC CIK
- 0000075252
In the last 90 days, Accendra Health Inc insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Other share classesACH
Key figures
- Market capClose on Nov 16, 2026
- $6.59M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.05K in total
- 1
- 13F holdersQ3 2026
- 0
- 13F valueReported value at the end of Q3 2026
- $0
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.76B
- −74.2% year over year
- Net income, FY2025
- -$1.10B
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $601.8M
- −13.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $1.10B (39.8% of revenue).
Superinvestors holding ACCH, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding ACCH at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Accendra Health Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:03 PM ET | Nov 16 | 1 day | Bernocchi Perry AOther: former Chief Operating Officer | SSale | −33.2K | $0.122 | −$4.05K | −10.6%280.8K after | 10b5-1 |
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 12 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +720.0K | $5.15 | +$3.71M | +6.2%12.3M after | |
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 13-14 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +817.9K | $5.37 | +$4.39M | +6.7%13.1M after | 2 lots |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 8 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +105.0K | $7.96 | +$835.8K | +0.9%11.3M after | |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 9-10 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +305.0K | $7.34 | +$2.24M | +2.7%11.6M after | 2 lots |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 3 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +160.0K | $8.53 | +$1.36M | +1.5%10.8M after | |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 4-7 | 3 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +368.4K | $7.94 | +$2.93M | +3.4%11.2M after | 2 lots |
| Mar 4, 2025 (view filing)9:07 PM ET | Feb 28 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +1.74M | $9.39 | +$16.3M | +22.5%9.47M after | |
| Mar 4, 2025 (view filing)9:07 PM ET | Mar 3-4 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +1.15M | $9.58 | +$11.1M | +12.2%10.6M after | 2 lots |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Leon Jonathan AEVP, Chief Financial Officer | SSale | −5.28K | $11.82 | −$62.4K | −3.9%130.8K after | 10b5-1 |
Top 10 13F holders, Q3 2026
View all: Top 10 13F holders, Q3 2026The largest institutional positions in Accendra Health Inc at the end of Q3 2026; share changes are against Q2 2026.
No institution reported holding ACCH in 13F filings for Q3 2026.